Target for drug development identified for triple-negative breast cancer
 

Often deadly "triple-negative" breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, according to a UC San Francisco researcher who described her discovery in a study published online in the journal Cancer Cell...

More...